Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese population

Journal of Neural Transmission

Volumn 120, Issue 11, 2013, Pages 1599-1603

  Shibata, Nobuto ^a   Nagata, Tomoyuki ^b   Shinagawa, Shunichiro ^b   Ohnuma, Tohru ^a   Shimazaki, Hiromi ^a   Komatsu, Miwa ^a   Kuerban, Bolati ^a   Tomson, Katrin ^a,c   Nakayama, Kazuhiko ^b   Yamada, Hisashi ^b   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Alzheimer's disease; APOA1; APOD; APOE; Polymorphism

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN D;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ALZHEIMER DISEASE; APOLIPOPROTEIN A-I; APOLIPOPROTEINS D; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JAPAN; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84887251171     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1036-7     Document Type: Article

References (19)

1. Chen Y, Jia L, Wei C, Wang F, Lv H, Jia J (2008) Association between polymorphisms in the apolipoprotein D gene and sporadic Alzheimer's disease. Brain Res 1233:196-202. doi: 10.1016/j.brainres.2008.07.018
2. Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI (2003) Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genet B Neuropsychiatr Genet 116B(1):98-101. doi: 10.1002/ajmg.b.10798
3. Glockner F, Ohm TG (2003) Hippocampal apolipoprotein D level depends on Braak stage and APOE genotype. Neuroscience 122(1):103-110
4. Helbecque N, Codron V, Cottel D, Amouyel P (2008) An apolipoprotein A-I gene promoter polymorphism associated with cognitive decline, but not with Alzheimer's disease. Dement Geriatr Cogn Disord 25(2):97-102. doi: 10.1159/000112176
5. Helisalmi S, Hiltunen M, Vepsalainen S, Iivonen S, Corder EH, Lehtovirta M, Mannermaa A, Koivisto AM, Soininen H (2004) Genetic variation in apolipoprotein D and Alzheimer's disease. J Neurol 251(8):951-957. doi: 10.1007/s00415-004-0470-8
6. Koldamova RP, Lefterov IM, Lefterova MI, Lazo JS (2001) Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity. Biochemistry 40(12):3553-3560
7. Lefterov I, Fitz NF, Cronican AA, Fogg A, Lefterov P, Kodali R, Wetzel R, Koldamova R (2010) Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1DeltaE9 mice. J Biol Chem 285(47):36945-36957. doi: 10.1074/jbc.M110.127738
8. Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L (2010) Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease. J Biol Chem 285(47):36958-36968. doi: 10.1074/jbc.M110.127829
9. Martinez E, Navarro A, Ordonez C, Del Valle E, Tolivia J (2012) Amyloid-beta25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells. J Alzheimers Dis 30(2):233-244. doi: 10.3233/JAD-2012-112102
10. Merched A, Xia Y, Visvikis S, Serot JM, Siest G (2000) Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 21(1):27-30
11. Muffat J, Walker DW, Benzer S (2008) Human APOD, an apolipoprotein up-regulated in neurodegenerative diseases, extends lifespan and increases stress resistance in Drosophila. Proc Natl Acad Sci USA 105(19):7088-7093. doi: 10.1073/pnas.0800896105
12. Navarro A, Del Valle E, Astudillo A, Gonzalez del Rey C, Tolivia J (2003) Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp Neurol 184(2):697-704. doi: 10.1016/S0014-4886(03)00315-7
13. Ordonez C, Navarro A, Perez C, Martinez E, del Valle E, Tolivia J (2012) Gender differences in apolipoprotein D expression during aging and in Alzheimer disease. Neurobiol Aging 33(2):433 e411-e420. doi: 10.1016/j.neurobiolaging. 2011.01.010
14. Paula-Lima AC, Tricerri MA, Brito-Moreira J, Bomfim TR, Oliveira FF, Magdesian MH, Grinberg LT, Panizzutti R, Ferreira ST (2009) Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. Int J Biochem Cell Biol 41(6):1361-1370. doi: 10.1016/j.biocel.2008.12.003
15. Smach MA, Edziri H, Charfeddine B, Ben Othman L, Lammouchi T, Ltaief A, Nafati S, Dridi H, Bennamou S, Limem K (2011) Polymorphism in APOA1 Influences high-density lipoprotein cholesterol levels but is not a major risk factor of Alzheimer's disease. Dement Geriatr Cogn Dis Extra 1(1):249-257. doi: 10.1159/000329910
16. Song F, Poljak A, Crawford J, Kochan NA, Wen W, Cameron B, Lux O, Brodaty H, Mather K, Smythe GA, Sachdev PS (2012) Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals. PLoS ONE 7(6):e34078. doi: 10.1371/journal.pone.0034078
17. Thomas EA, Laws SM, Sutcliffe JG, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN (2003) Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol Psychiatry 54(2):136-141
18. Vollbach H, Heun R, Morris CM, Edwardson JA, McKeith IG, Jessen F, Schulz A, Maier W, Kolsch H (2005) APOA1 polymorphism influences risk for early-onset nonfamiliar AD. Ann Neurol 58(3):436-441. doi: 10.1002/ana.20593
19. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337(8750):1158-1159